Intestinal Microbiota Contributes to the Improvement of Alcoholic Hepatitis in Mice Treated With Schisandra chinensis Extract
Open Access
- 18 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 822429
Abstract
Alcoholic hepatitis (AH) has a high short-term mortality rate. Schisandra chinensis has the potential to ameliorate liver damage and be a source of prebiotics. We aimed to investigate whether Schisandra chinensis extract (SCE) can improve AH and the role of the small intestinal and cecal microbiota and their metabolites. UHPLC-QE-MS was used to analyze the chemical components of SCE. The chronic-plus-binge ethanol feeding model was used to induce AH in mice. 1H NMR was used to analyze intestinal metabolites. 16S rRNA-based high throughput sequencing was used to evaluate the effects of SCE on intestinal microbiota (IM). Intestinal microbiota transplantation was used to explore the role of IM in SCE treatment of AH. SCE ameliorated AH non-dose-dependently. SCE effectively improved liver inflammation and oxidative/nitrosative stress, strengthened intestinal barrier function, and regulated the composition of IM and the content of short-chain fatty acids (SCFAs) in AH mice. Samples from in vivo and in vitro SCE-altered IM improved liver status and regulated the IM. The administration of Lactobacillus plantarum and Bifidobacterium breve ameliorated AH to some extent. The administration of Enterococcus faecalis and Klebsiella oxytoca had partial beneficial effects on AH. Collectively, IM and metabolites were closely associated with the improvement of SCE on AH. The possible microbe targets were the growth inhibition of Escherichia-Shigella and the expansion of SCFA producers, such as Lactobacillus and Bifidobacterium. Schisandra chinensis can be considered as a safe and effective dietary supplement for the prevention and improvement of AH.Keywords
Funding Information
- Department of Science and Technology of Jilin Province (20200708072YY, 20210401122YY)
This publication has 52 references indexed in Scilit:
- Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in miceDrug Design, Development and Therapy, 2014
- Alterations of the gut microbiome and metabolome in alcoholic liver diseaseWorld Journal of Gastrointestinal Pathophysiology, 2014
- Mouse model of chronic and binge ethanol feeding (the NIAAA model)Nature Protocols, 2013
- Long‐term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosisJournal of Gastroenterology and Hepatology, 2013
- Contribution of Gut Bacteria to Liver PathobiologyGastroenterology Research and Practice, 2010
- Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot studyAlcohol, 2008
- Toll–Like Receptor 4 Is Involved in the Mechanism of Early Alcohol–Induced Liver Injury in MiceHepatology, 2001
- Determination of the mechanical impact force in the in vitro dissolution test and evaluation of the correlation between in vivo and in vitro releaseInternational Journal of Pharmaceutics, 1993
- Effect of lactic acid on growth and butanediol production byKlebsiella oxytocaJournal of Industrial Microbiology and Biotechnology, 1989
- EFFECT OF CULTURE MEDIUM AND CARBON DIOXIDE CONCENTRATION ON GROWTH OF ANAEROBIC BACTERIA AND MEDIUM pHActa Pathologica Microbiologica Scandinavica Series B: Microbiology, 1986